Cannabis use, attitudes, and legal status in the U.S.: A review

Preventive Medicine

Volumn 104, Issue , 2017, Pages 13-23

  Carliner, Hannah ^a,b,c   Brown, Qiana L ^b,d,e   Sarvet, Aaron L ^c   Hasin, Deborah S ^a,b,c  

^a Department of Psychiatry ^*  (United States)

^b Department of Medicine   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d NEW YORK STATE OFFICE OF MENTAL HEALTH   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabis; Epidemiology; Marijuana; Medical marijuana; National surveys

Indexed keywords

CANNABIS ADDICTION; CANNABIS SMOKING; CANNABIS USE; CULTURAL FACTOR; HARM REDUCTION; HUMAN; INCOME; INFORMATION DISSEMINATION; LAW; LAW ENFORCEMENT; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLIC OPINION; RACE DIFFERENCE; REVIEW; SEX RATIO; UNITED STATES; ATTITUDE; COMPLICATION; DRUG DEPENDENCE; EPIDEMIOLOGY; LEGISLATION AND JURISPRUDENCE; PSYCHOLOGY; QUESTIONNAIRE; RECREATION; RISK;

CANNABIS; MEDICAL CANNABIS;

ATTITUDE; CANNABIS; HUMANS; MARIJUANA ABUSE; MARIJUANA SMOKING; MEDICAL MARIJUANA; PREVALENCE; RECREATION; RISK; SUBSTANCE-RELATED DISORDERS; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 85026286721     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2017.07.008     Document Type: Review

References (102)

1. Aldrich, M.R., Mikuriya, T., Savings in California marijuana law enforcement costs attributable to the Moscone Act of 1976–a summary. J. Psychoactive Drugs 20 (1988), 75–81.
2. American College of Obstetricians and Gynecologists Committee on Obstetric Practice, Committee opinion no. 637: marijuana use during pregnancy and lactation. Obstet. Gynecol. 126 (2015), 234–238.
3. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 5th ed., 2013, American Psychiatric Publishing, Arlington, VA.
4. Angrist, J.D., Pischke, J.-S., Mostly Harmless Econometrics: An Empiricist's Companion. 2008, Princeton University Press.
5. Annas, G.J., Reefer madness–the federal response to California's medical-marijuana law. N. Engl. J. Med. 337 (1997), 435–439.
6. Azofeifa, A., Mattson, M.E., Schauer, G., McAfee, T., Grant, A., Lyerla, R., National estimates of marijuana use and related indicators - National Survey on Drug Use and Health, United States, 2002–2014. Morbidity And Mortality Weekly Report Surveillance Summaries (Washington, D.C.: 2002), 65, 2016, 1–28.
7. Bellum, S., Blast from the past: “Just Say No”. Teens, N.I.o.D.A.f., (eds.) Drugs & Health Blog, 2011.
8. Bestrashniy, J., Winters, K.C., Variability in medical marijuana laws in the United States. Psychol. Addict. Behav. 29 (2015), 639–642.
9. Bonn-Miller, M.O., Harris, A.H., Trafton, J.A., Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009. Psychol. Serv. 9 (2012), 404–416.
10. Brady, J.E., Li, G., Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999–2010. Am. J. Epidemiol. 179 (2014), 692–699.
11. Brown, Q.L., Sarvet, A.L., Shmulewitz, D., Martins, S.S., Wall, M.M., Hasin, D.S., Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002–2014. JAMA 317 (2017), 207–209.
12. Brownell, G.S., Marijuana and the law in California: a historical and political overview. J. Psychoactive Drugs 20 (1988), 71–74.
13. Budney, A.J., Hughes, J.R., Moore, B.A., Vandrey, R., Review of the validity and significance of cannabis withdrawal syndrome. Am. J. Psychiatr. 161 (2004), 1967–1977.
14. Calvigioni, D., Hurd, Y.L., Harkany, T., Keimpema, E., Neuronal substrates and functional consequences of prenatal cannabis exposure. Eur. Child Adolesc. Psychiatry 23 (2014), 931–941.
15. Carliner, H., Mauro, P.M., Brown, Q.L., Shmulewitz, D., Rahim-Juwel, R., Sarvet, A.L., Wall, M.M., Martins, S.S., Carliner, G., et al. The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002–2014. Drug Alcohol Depend. 170 (2017), 51–58.
16. Caulkins, J.P., Kilmer, B., MacCoun, R.J., Pacula, R.L., Reuter, P., Design considerations for legalizing cannabis: lessons inspired by analysis of California's Proposition 19. Addiction 107 (2012), 865–871.
17. Center for Behavioral Health Statistics and Quality, Key Substance Use and Mental Health Indicators in the United States: Results From the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 16-4984, NSDUH Series H-51). 2016.
18. Cerdá M., Wall, M., Keyes, K.M., Galea, S., Hasin, D., Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend. 120 (2012), 22–27.
19. Cerdá M., Moffitt, T.E., Meier, M.H., Harrington, H., Houts, R., Ramrakha, S., Hogan, S., Poulton, R., Caspi, A., Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: a longitudinal cohort study. Clinical Psychological Science 4 (2016), 1028–1046.
20. Cerdá M., Wall, M., Feng, T., Keyes, K.M., Sarvet, A., Schulenberg, J., O'Malley, P.M., Pacula, R.L., Galea, S., et al. State recreational marijuana laws and adolescent marijuana use. JAMA Pediatr. 171:2 (2017), 142–149, 10.1001/jamapediatrics.2016.3624.
21. Charilaou, P., Agnihotri, K., Garcia, P., Badheka, A., Frenia, D., Yegneswaran, B., Trends of cannabis use disorder in the inpatient: 2002 to 2011. Am. J. Med., 130(678–87), 2017, e7.
22. Chu, Y.-W.L., The effects of medical marijuana laws on illegal marijuana use. J. Health Econ. 38 (2014), 43–61.
23. Compton, W.M., Grant, B.F., Colliver, J.D., Glantz, M.D., Stinson, F.S., Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA 291 (2004), 2114–2121.
24. Compton, W.M., Gfroerer, J., Conway, K.P., Finger, M.S., Unemployment and substance outcomes in the United States 2002–2010. Drug Alcohol Depend. 142 (2014), 350–353.
25. Compton, W.M., Han, B., Jones, C.M., Blanco, C., Hughes, A., Marijuana use and use disorders in adults in the USA, 2002–14: analysis of annual cross-sectional surveys. Lancet Psychiatry 3 (2016), 954–964.
26. Danielsson, A.K., Falkstedt, D., Hemmingsson, T., Allebeck, P., Agardh, E., Cannabis use among Swedish men in adolescence and the risk of adverse life course outcomes: results from a 20 year-follow-up study. Addiction 110 (2015), 1794–1802.
27. Davis, J.M., Mendelson, B., Berkes, J.J., Suleta, K., Corsi, K.F., Booth, R.E., Public health effects of medical marijuana legalization in Colorado. Am. J. Prev. Med. 50 (2016), 373–379.
28. Desrosiers, N.A., Ramaekers, J.G., Chauchard, E., Gorelick, D.A., Huestis, M.A., Smoked cannabis’ psychomotor and neurocognitive effects in occasional and frequent smokers. J. Anal. Toxicol. 39 (2015), 251–261.
29. Eddy, M., Medical Marijuana: Review and Analysis of Federal and State Policies. Report to United States Congress. 2010.
30. Fergusson, D.M., Boden, J.M., Cannabis use and later life outcomes. Addiction 103 (2008), 969–976.
31. Fergusson, D.M., Boden, J.M., Horwood, L.J., Psychosocial sequelae of cannabis use and implications for policy: findings from the Christchurch Health and Development Study. Soc. Psychiatry Psychiatr. Epidemiol. 50 (2015), 1317–1326.
32. Freisthler, B., Gruenewald, P.J., Examining the relationship between the physical availability of medical marijuana and marijuana use across fifty California cities. Drug Alcohol Depend., 2014, 244–250.
33. Gallup, Support for Legal Marijuana Use Up to 60% in U.S. 2016.
34. Golub, A., Johnson, B.D., Dunlap, E., The race/ethnicity disparity in misdemeanor marijuana arrests in New York City. Criminology & Public Policy 6 (2007), 131–164.
35. Grant, B.F., Goldstein, R.B., Smith, S.M., Jung, J., Zhang, H., Chou, S.P., Pickering, R.P., Ruan, W.J., Huang, B., et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample. Drug Alcohol Depend. 148 (2015), 27–33.
36. Gubatan, J., Staller, K., Barshop, K., Kuo, B., Cannabis abuse is increasing and associated with increased emergency department utilization in gastroenterology patients. Dig. Dis. Sci. 61 (2016), 1844–1852.
37. Hall, W., Alcohol and cannabis: comparing their adverse health effects and regulatory regimes. Int J Drug Policy 42 (2017), 57–62.
38. Hall, W., Lynskey, M., Why it is probably too soon to assess the public health effects of legalisation of recreational cannabis use in the USA. Lancet Psychiatry 3 (2016), 900–906.
39. Haney, M., Hart, C.L., Vosburg, S.K., Comer, S.D., Reed, S.C., Foltin, R.W., Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology 197 (2008), 157–168.
40. Hasin, D.S., Grant, B.F., NESARC findings on increased prevalence of marijuana use disorders—consistent with other sources of information. JAMA psychiatry, 73, 2016 (532-32).
41. Hasin, D.S., Keyes, K.M., Alderson, D., Wang, S., Aharonovich, E., Grant, B.F., Cannabis withdrawal in the United States: results from NESARC. J. Clin. Psychiatry 69 (2008), 1354–1363.
42. Hasin, D.S., O'Brien, C.P., Auriacombe, M., Borges, G., Bucholz, K., Budney, A., Compton, W.M., Crowley, T., Ling, W., et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am. J. Psychiatr. 170 (2013), 834–851.
43. Hasin, D.S., Greenstein, E., Aivadyan, C., Stohl, M., Aharonovich, E., Saha, T., Goldstein, R., Nunes, E.V., Jung, J., et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. Drug Alcohol Depend. 148 (2015), 40–46.
44. Hasin, D.S., Saha, T.D., Kerridge, B.T., Goldstein, R.B., Chou, S.P., Zhang, H., Jung, J., Pickering, R.P., Ruan, W.J., et al. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry 72 (2015), 1235–1242.
45. Hasin, D.S., Wall, M., Keyes, K.M., Cerdá M., Schulenberg, J., O'Malley, P.M., Galea, S., Pacula, R., Feng, T., Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys. Lancet Psychiatry 2 (2015), 601–608.
46. Hasin, D.S., Kerridge, B.T., Saha, T.D., Huang, B., Pickering, R., Smith, S.M., Jung, J., Zhang, H., Grant, B.F., Prevalence and correlates of DSM-5 cannabis use disorder, 2012–2013: findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Am. J. Psychiatr. 173 (2016), 588–599.
47. Hasin, D.S., Kerridge, B., Sarvet, A.L., Wall, M.M., Greater Increases in Cannabis Use and Cannabis Use Disorder Among U.S. Men, Young Adults and Those in Low-income Households. 2017 (In preparation).
48. Hasin, D.S., Sarvet, A.L., Cerda, M., Keyes, K.M., Galea, S., Wall, M.M., Driving under the influence of cannabis or alcohol: relationship to medical marijuana laws, 1991–1992 to 2012–2013. Annual Meeting of the Reseearch Society on Alcoholism, 2017, Denver, Colorado.
49. Hasin, D.S., Sarvet, A.L., Cerda, M., Keyes, K.M., Galea, S., Wall, M.M., U.S. illicit cannabis use, cannabis use disorders, and medical marijuana laws, 1991–1992 to 2012–2013. Annual Meeting of the College on Problems of Drug Dependence, 2017, Montreal, Canada.
50. Hasin, D.S., Sarvet, A.L., Cerda, M., Keyes, K.M., Stohl, M., Galea, S., Wall, M.M., U.S. Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991–1992 to 2012–2013. JAMA Psychiatry 74:6 (2017), 579–588, 10.1001/jamapsychiatry.2017.0724.
51. Henkel, D., Unemployment and substance use: a review of the literature (1990–2010). Current Drug Abuse Reviews 4 (2011), 4–27.
52. Hunt, P.E., Miles, J., The impact of legalizing and regulating weed: issues with study design and emerging findings in the USA. 2015, Springer Berlin Heidelberg, Berlin, Heidelberg, 1–26.
53. Imbens, G.W., Wooldridge, J.M., Recent developments in the econometrics of program evaluation. J. Econ. Lit. 47 (2009), 5–86.
54. Jensen, E.L., Roussell, A., Field observations of the developing legal recreational cannabis economy in Washington State. Int J Drug Policy 33 (2016), 96–101.
55. Johnson, J., Hodgkin, D., Harris, S.K., The design of medical marijuana laws and adolescent use and heavy use of marijuana: analysis of 45 states from 1991 to 2011. Drug Alcohol Depend. 170 (2017), 1–8.
56. Kerr, W.C., Greenfield, T.K., Bond, J., Ye, Y., Rehm, J., Age–period–cohort influences on trends in past year marijuana use in the US from the 1984, 1990, 1995 and 2000 National Alcohol Surveys. Drug Alcohol Depend. 86 (2007), 132–138.
57. Keyes, K.M., Grant, B.F., Hasin, D.S., Evidence for a closing gender gap in alcohol use, abuse, and dependence in the United States population. Drug Alcohol Depend. 93 (2008), 21–29.
58. Keyes, K.M., Li, G., Hasin, D.S., Birth cohort effects and gender differences in alcohol epidemiology: a review and synthesis. Alcohol. Clin. Exp. Res. 35 (2011), 2101–2112.
59. Keyes, K.M., Wall, M., Cerdá M., Schulenberg, J., O'Malley, P.M., Galea, S., Feng, T., Hasin, D.S., How Does State Marijuana Policy Affect U.S. Youth? Medical Marijuana Laws, Marijuana Use and Perceived Harmfulness: 1991–2014. Addiction. 2016, Abingdon, England.
60. Kilmer, B., Recreational cannabis - minimizing the health risks from legalization. N. Engl. J. Med. 376 (2017), 705–707.
61. King, R.S., Mauer, M., The war on marijuana: the transformation of the war on drugs in the 1990s. Harm Reduction Journal, 3, 2006.
62. Ko, J.Y., Farr, S.L., Tong, V.T., Creanga, A.A., Callaghan, W.M., Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age. Am. J. Obstet. Gynecol., 213(201), 2015 (e1-01 e10).
63. Lanza, S.T., Vasilenko, S.A., Dziak, J.J., Butera, N.M., Trends among U.S. high school seniors in recent marijuana use and associations with other substances: 1976–2013. J. Adolesc. Health 57 (2015), 198–204.
64. Liu, C., Huang, Y., Pressley, J.C., Restraint use and risky driving behaviors across drug types and drug and alcohol combinations for drivers involved in a fatal motor vehicle collision on U.S. roadways. Injury Epidemiology, 3(9), 2016.
65. Lubman, D.I., Cheetham, A., Yücel, M., Cannabis and adolescent brain development. Pharmacol. Ther. 148 (2015), 1–16.
66. Lynskey, M., Hall, W., Cannabis use and cannabis use disorders. Lancet Psychiatry 3 (2016), 911–912.
67. MacCoun, R., Pacula, R.L., Chriqui, J., Harris, K., Reuter, P., Do citizens know whether their state has decriminalized marijuana? Assessing the perceptual component of deterrence theory. Review of Law and Economics 5 (2009), 347–371.
68. Martins, S.S., Mauro, C.M., Santaella-Tenorio, J., Kim, J.H., Cerda, M., Keyes, K.M., Hasin, D.S., Galea, S., Wall, M., State-level medical marijuana laws, marijuana use and perceived availability of marijuana among the general U.S. population. Drug Alcohol Depend. 169 (2016), 26–32.
69. Mauro, P.M., Santaella-Tenorio, J., Mauro, C.M., Kim, J.H., Martins, S.S., Do people know if their state legally approved medical marijuana? Trends across the United States, 2004–2013. 2016 Annual Meeting of the Society for Epidemiologic Research, 2016, Miami, FL.
70. Mauro, P., Shmulewitz, D., Hasin, D., Sarvet, A.L., Rahim-Juwel, R., Brown, Q., et al. Age differences in adult past-year marijuana use and risk perceptions in the US, 2002–2013. Drug Alcohol Depend., 171, 2017, e134.
71. McGinty, E.E., Niederdeppe, J., Heley, K., Barry, C.L., Public perceptions of arguments supporting and opposing recreational marijuana legalization. Prev. Med. 99 (2017), 80–86.
72. McKay, M.P., Groff, L., 23 years of toxicology testing fatally injured pilots: implications for aviation and other modes of transportation. Accid. Anal. Prev. 90 (2016), 108–117.
73. McKenna, G.J., The current status of medical marijuana in the United States. Hawai'i journal of medicine & public health: a journal of Asia Pacific Medicine & Public Health 73 (2014), 105–108.
74. Meier, M.H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R.S., McDonald, K., Ward, A., Poulton, R., et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), E2657–E2664.
75. Musto, D.F., Opium, cocaine and marijuana in American history. Sci. Am. 265 (1991), 40–47.
76. Ogden, D.W., Memorandum for Selected United State Attorneys on Investigations and Prosecutions in States Authorizing the Medical Use of Marijuana. 2009, U.S. Department of Justice.
77. Pacek, L.R., Mauro, P.M., Martins, S.S., Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race/ethnicity. Drug Alcohol Depend. 149 (2015), 232–244.
78. Pacula, R.L., Examining the Impact of Marijuana Legalization on Marijuana Consumption: Insights from the Economics Literature. 2010, RAND Corporation, Santa Monica, CA.
79. Pacula, R.L., Chriqui, J.F., Reichmann, D.A., Terry-McElrath, Y.M., State medical marijuana laws: understanding the laws and their limitations. J. Public Health Policy 23 (2002), 413–439.
80. Pacula, R.L., Powell, D., Heaton, P., Sevigny, E.L., Assessing the Effects of Medical Marijuana Laws on Marijuana and Alcohol Use: The Devil is in the Details. 2013, National Bureau of Economic Research.
81. Pacula, R.L., Kilmer, B., Wagenaar, A.C., Chaloupka, F.J., Caulkins, J.P., Developing public health regulations for marijuana: lessons from alcohol and tobacco. Am. J. Public Health 104 (2014), 1021–1028.
82. Pacula, R.L., Powell, D., Heaton, P., Sevigny, E.L., Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details. Journal of Policy Analysis and Management 34 (2015), 7–31.
83. ProCon.org, 28 Legal Medical Marijuana States and DC. 2016.
84. Room, R., Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond. Addiction 109 (2014), 345–351.
85. Salomonsen-Sautel, S., Min, S.J., Sakai, J.T., Thurstone, C., Hopfer, C., Trends in fatal motor vehicle crashes before and after marijuana commercialization in Colorado. Drug Alcohol Depend. 140 (2014), 137–144.
86. Sarvet, A.L., Wall, M.M., Keyes, K.M., Cerdá M., Schulenberg, J., O'Malley, P.M., Hasin, D.S., Rapid recent increases in perceptions that marijuana is not harmful: unaccompanied by increases in adolescent marijuana use. Annual Meeting of the Society for Epidemiologic Research, 2017, Seattle, Washington.
87. Schlosser, E., Reefer Madness. 1994, The Atlantic.
88. Schuermeyer, J., Salomonsen-Sautel, S., Price, R.K., Balan, S., Thurstone, C., Min, S.J., Sakai, J.T., Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003–11. Drug Alcohol Depend. 140 (2014), 145–155.
89. Shi, Y., Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever. Drug Alcohol Depend. 173 (2017), 144–150.
90. Shmulewitz, D., Brown, Q.L., Rahim-Juwel, R., Martins, S.S., Wall, M.M., Mauro, P.M., Carliner, H., Sarvet, A.L., Hasin, D.S., US trends in past-year marijuana use and perceived risk of regular use, 2002–2014, by race/ethnicity. Annual Meeting of the College on Problems of Drug Dependence Palm Springs, CA, 2016.
91. Stinson, F.S., Ruan, W.J., Pickering, R., Grant, B.F., Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol. Med. 36 (2006), 1447–1460.
92. Stolzenberg, L., D'Alessio, S.J., Dariano, D., The effect of medical cannabis laws on juvenile cannabis use. Int J Drug Policy 27 (2016), 82–88.
93. Substance Abuse and Mental Health Services Administration, Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48. 2014, Substance Abuse and Mental Health Services Administration, Rockville, MD.
94. Survey Research Center, Monitoring the Future. 2016, Institute for Social Research, University of Michigan, Ann Arbor, MI.
95. United States Congress, House Committee on the Judiciary, Subcommittee on Crime, Medical Marijuana Referenda Movement in America: Hearing Before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, One Hundred Fifth Congress, First Session, October 1, 1997. 1997, U.S. Government Printing Office.
96. Volkow, N.D., Baler, R.D., Compton, W.M., Weiss, S.R., Adverse health effects of marijuana use. N. Engl. J. Med. 370 (2014), 2219–2227.
97. Volkow, N.D., Compton, W.M., Wargo, E.M., The Risks of Marijuana Use During Pregnancy. 2016 (JAMA).
98. Wall, M.M., Poh, E., Cerdá M., Keyes, K.M., Galea, S., Hasin, D.S., Adolescent marijuana use from 2002 to 2008: higher in states with medical marijuana laws, cause still unclear. Ann. Epidemiol. 21 (2011), 714–716.
99. Wall, M.M., Mauro, C., Hasin, D.S., Keyes, K.M., Cerda, M., Martins, S.S., Feng, T., Prevalence of marijuana use does not differentially increase among youth after states pass medical marijuana laws: commentary on and reanalysis of US National Survey on Drug Use in Households data 2002–2011. Int J Drug Policy 29 (2016), 9–13.
100. Wen, H., Hockenberry, J.M., Cummings, J.R., The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. J. Health Econ. 42 (2015), 64–80.
101. White, M.C., ‘This is your brain on drugs’ Tweaked for Today's Parents. 2016, New York Times.
102. Zhu, H., Wu, L.T., Trends and correlates of cannabis-involved emergency department visits: 2004 to 2011. J. Addict. Med. 10 (2016), 429–436.